Shares of Flexion Therapeutics (NASDAQ:FLXN) have risen by about 25% since I called the stock an ideal run-up candidate.
Key points for the bull thesis included the following:
Boston
Shares of Flexion Therapeutics (NASDAQ:FLXN) have risen by about 25% since I called the stock an ideal run-up candidate.
Key points for the bull thesis included the following:
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2026 citybuzz